x
COVID-19 TRIBAL RESOURCE CENTER
« Return to Tobacco Cessation Page

Tobacco Cessation Legislative Updates

  • H.R.2339, the “Reversing the Youth Tobacco Epidemic Act,” was introduced by Pallone and Rep. Donna Shalala (D-FL). The legislation prohibits flavored tobacco products, including e-cigarettes, increases the minimum age for purchasing tobacco products to 21, bans all non-face-to-face sales for tobacco products, and protects kids from the marketing of tobacco products.
  • October 16, 2019
    Hearing on “Legislation to Reverse the Youth Tobacco Epidemic” Available here.
  • October 30, 2019: Congressman Pallone Urges President Trump to Issue E-cigarette Flavor Ban
    Congressman Frank Pallone, Jr. (D-NJ) who serves as the Energy and Commerce Chairman sent a letter to President Trump on Wednesday, October 30, 2019, urging him to follow through on the promise he made in an Oval Office press conference to ban flavored e-cigarette products.
  • November 13, 2019
    The Health Subcommittee advanced the Reversing the Youth Tobacco Epidemic. See video clip here.
  • November 14, 2019: Pallone Urges FDA to Investigate Allegations that JUUL Knowingly Sold Contaminated E-Cigarette Pods.
    Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) sent a letter to Food and Drug Administration (FDA) Acting Commissioner Brett P. Giroir urging the agency to investigate allegations that JUUL Labs, Inc. knowingly distributed approximately one million contaminated mint-flavored e-cigarette pods for consumer use.   Read more here.
  • November 19, 2019: Pallone on Passage of Reversing Youth Tobacco Epidemic Act.
    Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) released the following statement today after the Reversing the Youth Tobacco Epidemic Act (H.R. 2339), which he originally introduced in April, was favorably reported, as amended, to the full House of Representatives by a vote of 28-24. Read more here.









NIHB Contacts:

Public Health Policy and Programs

National Indian Health Board
50 F St NW, Suite 600
Washington, DC 20001
Phone: 202-507-4070

National Indian Health Board
50 F St NW, Suite 600 | Washington, DC 20001 | Phone: 202-507-4070 | Email: [email protected]